Gait in Young Children With NF1
ConditionNeurofibromatosis Type 1
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 71
SponsorNYU Langone Health
About this trial
The objective of this study is to develop office-based tools to quantify gait in young children with NF1 that reflect overall gross motor impairment and predict future gross motor difficulties.
Eligibility criteria
Qualifiers
Children who are independently ambulatory who meet revised diagnostic criteria for NF1
Children less than or equal to 71 months of age
Parent/Legal Guardian willing and able to provide parental consent.
Disqualifiers
Age ≥ 6 years old, inability to walk 10 meters independently, non-NF1 medical illness that alters their physical or neurological abilities that could significantly impact their performance.
Parent/Legal Guardian not willing and able to provide parental consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
56 Participants
are grouped into 1 trial groupLocations
Sponsors and collaborators
NYU Langone Health
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Source ClinicalTrials.gov